Search Results

You are looking at 41 - 50 of 168 items for :

  • All content x
Clear All
Full access

Dominik J. Ose, Richard Viskochil, Andreana N. Holowatyj, Mikaela Larson, Dalton Wilson, William A. Dunson Jr, Vikrant G. Deshmukh, J. Ryan Butcher, Belinda R. Taylor, Kim Svoboda, Jennifer Leiser, Benjamin Tingey, Benjamin Haaland, David W. Wetter, Simon J. Fisher, Mia Hashibe, and Cornelia M. Ulrich

patients, 49.1% (n=1,724) were female, 90.5% (n=3,177) were non-Hispanic White, 60.4% (n=2,122) were overweight or obese, and 70.2% (n=2,464) were Utah residents ( Table 2 ). Table 2. Clinicodemographic Characteristics Among Patients With Cancer

Full access

Reece J. Knippel and Cynthia L. Sears

syndrome and familial adenomatous polyposis (FAP), are well described, they contribute to a minority of CRC cases. 1 Most CRC cases arise sporadically as a direct result of environmental stimuli. 1 Factors including obesity, smoking, alcohol consumption

Full access

Srinivas K. Tantravahi, and Theresa L. Werner

Case Report A 56-year-old gravida 12, para 7, morbidly obese woman with hypertension and stage IA endometrial cancer diagnosed in June 2011 was seen in a medical oncology clinic after local recurrence at the vaginal cuff. She initially

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, Muhammad Raza, M. Alma Rodriguez, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

lifestyle goals may be difficult for many survivors, even small reductions in weight among overweight or obese survivors or small increases in physical activity among sedentary individuals are thought to yield meaningful improvements in cancer

Full access

Jake B. Guinto and Audrea H. Szabatura

inappropriate for certain drugs, such as carboplatin or monoclonal antibodies, or for some patient populations, such as pediatric patients or those who are significantly obese or underweight. Additionally, our institution treats a significant number of

Full access

NCCN Guidelines Insights: Survivorship, Version 2.2020

Featured Updates to the NCCN Guidelines

Crystal S. Denlinger, Tara Sanft, Javid J. Moslehi, Linda Overholser, Saro Armenian, K. Scott Baker, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Norah Lynn Henry, Christine Hill-Kayser, Melissa Hudson, Nazanin Khakpour, Divya Koura, Allison L. McDonough, Michelle Melisko, Kathi Mooney, Halle C. F. Moore, Natalie Moryl, Tracey O’Connor, Electra D. Paskett, Chirayu Patel, Lindsay Peterson, William Pirl, M. Alma Rodriguez, Kathryn J. Ruddy, Lillie Shockney, Sophia Smith, Karen L. Syrjala, Amye Tevaarwerk, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

heart failure in cancer survivors. These risk factors include well-established and well-studied risk factors, such as tobacco use, obesity, and poor health behaviors, as well as recently discovered ones. For example, somatic mutations in blood cells

Full access

Sherif R. Z. Abdel-Misih, Lai Wei, Al B. Benson III, Steven Cohen, Lily Lai, John Skibber, Neal Wilkinson, Martin Weiser, Deborah Schrag, and Tanios Bekaii-Saab

factor in lymph node yield due to inadequate specimen analysis and processing. Patient-related factors, such as age and obesity, have been associated with decreased lymph node yield. 13 – 16 Institutional-related factors demonstrate variation and high

Full access

Emily van Seventer, J. Peter Marquardt, Amelie S. Troschel, Till D. Best, Nora Horick, Chinenye Azoba, Richard Newcomb, Eric J. Roeland, Michael Rosenthal, Christopher P. Bridge, Joseph A. Greer, Areej El-Jawahri, Jennifer Temel, Florian J. Fintelmann, and Ryan D. Nipp

increases BMI. This detail may also play a role in the “obesity paradox” concept, a phenomenon in which patients with higher BMI experience favorable survival outcomes in oncology. 6 , 50 , 51 Notably, radiodensity may play a role in the obesity paradox by

Full access

, annual standardized prevalence rates in the overall CML population were 20%, 30%, and 40% higher for hypertension, diabetes, and obesity, respectively. When stratified by SB residence status, annual standardized prevalence rates among SB residents with

Full access

Darren R. Feldman, Wendy L. Schaffer, and Richard M. Steingart

> 850 mg; P < .001). 38 These findings remained significant after adjusting for testosterone levels and body mass index (BMI). Obesity has also been reported as increased in GCT survivors treated with chemotherapy. With a cutoff BMI of 25 or more, the